Randomized comparative bioavailability of a novel 3D printed fast melt formulation of levetiracetam following the administration of a single 1000 mg dose to healthy human volunteers under fasting and fed conditions

By: Julie Massicotte1, Sophie Boudriau1, Cecilia Hanzel1, Laura Sayegh1, Jing Wang1, Doug Plessinger2, Nemichand Jain2 and Marc Lefebvre1

1Algorithme Pharma Inc., Laval, QC, Canada
2Aprecia Pharmaceuticals Company, Langhorne, PA, USA

Click on the link below to request this poster's reprint.